UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer

被引：0
|
作者：
Yoshinori Miyata
Tetsuo Touyama
Takaya Kusumi
Yoshitaka Morita
Nobuyuki Mizunuma
Fumihiro Taniguchi
Mitsuaki Manabe
机构：
[1] Saku Central Hospital Advanced Care Center,Department of Medical Oncology
[2] Nakagami Hospital,Department of Surgery
[3] Keiyukai Sapporo Hospital,Department of Surgery
[4] National Hospital Organization Kobe Medical Center,Department of Radiology
[5] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
[6] Japanese Red Cross Kyoto Daiichi Hospital,Hepato
[7] Yakult Honsha Co.,Pancreatic Surgery Division
[8] Ltd.,undefined
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Colorectal; Irinotecan; Neutropenia; Polymorphism; UGT1A1 enzyme;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：696 / 703
页数：7
相关论文
共 50 条
  • [41] Polymorphisms of the UDP-Glucuronosyl Transferase 1A Genes Are Associated with Adverse Events in Cancer Patients Receiving Irinotecan-Based Chemotherapy
    Inoue, Kazuyuki
    Sonobe, Momoyo
    Kawamura, Yukinori
    Etoh, Takashi
    Takagi, Masakazu
    Matsumura, Takashi
    Kikuyama, Masataka
    Kimura, Midori
    Minami, Sato
    Utsuki, Hiroaki
    Yamazaki, Tomoaki
    Suzuki, Takayo
    Tsuji, Daiki
    Hayashi, Hideki
    Itoh, Kunihiko
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 229 (02): : 107 - 114
  • [42] Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
    Jada, Srinivasa Rao
    Lim, Robert
    Wong, Chiung Ing
    Shu, Xiaochen
    Lee, Soo Chin
    Zhou, Qingyu
    Goh, Boon Cher
    Chowbay, Balram
    CANCER SCIENCE, 2007, 98 (09): : 1461 - 1467
  • [43] UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI
    Hsieh, Yi-Chien
    Chang, Tsung-Kun
    Su, Wei-Chih
    Huang, Ching-Wen
    Tsai, Hsiang-Lin
    Chen, Yen-Cheng
    Li, Ching-Chun
    Chen, Po-Jung
    Yin, Tzu-Chieh
    Ma, Cheng-Jen
    Wang, Jaw-Yuan
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [44] Meta-analysis revisiting the influence of UGT1A1*28 and UGT1A1*6 on irinotecan safety in colorectal cancer patients
    Thu Nguyen, Cuc Thi
    Minh Thuy, Nguyen Thi
    Huong, Phung Thanh
    PHARMACOGENOMICS, 2024, 25 (10-11) : 469 - 477
  • [45] Pharmacogenetic clinical randomized phase II trial to evaluate the efficacy and safety of FOLFIRI with high dose of irinotecan (FOLFIRI-HD) in metastatic colorectal cancer patients according to UGT1A 1 genotype
    David, Paez
    Maria, Tobena
    Ana, Sebio
    Julen, Fernandez-Plana
    Marta, Martin
    Anna, Virgili
    Pau, Riera
    Ivana, Sullivan
    Juliana, Salazar
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] A UGT1A1*28 and*6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer
    Kim, Kyu-pyo
    Kim, Ho-Sook
    Sym, Sun Jin
    Bae, Kyun Seop
    Hong, Yong Sang
    Chang, Heung-Moon
    Lee, Jae Lyun
    Kang, Yoon-Koo
    Lee, Jung Shin
    Shin, Jae-Gook
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1609 - 1617
  • [47] A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer
    Kyu-pyo Kim
    Ho-Sook Kim
    Sun Jin Sym
    Kyun Seop Bae
    Yong Sang Hong
    Heung-Moon Chang
    Jae Lyun Lee
    Yoon-Koo Kang
    Jung Shin Lee
    Jae-Gook Shin
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1609 - 1617
  • [48] Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series
    Tsai, Hsiang-Lin
    Chen, Po-Jung
    Chen, Yen-Cheng
    Li, Ching-Chun
    Chang, Tsung-Kun
    Su, Wei-Chih
    Yin, Tzu-Chieh
    Huang, Ching-Wen
    Wang, Jaw-Yuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (07)
  • [49] Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients
    Gao, Jing
    Zhou, Jun
    Li, Yanyan
    Peng, Zhi
    Li, Yilin
    Wang, Xicheng
    Shen, Lin
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [50] Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients
    Jing Gao
    Jun Zhou
    Yanyan Li
    Zhi Peng
    Yilin Li
    Xicheng Wang
    Lin Shen
    Medical Oncology, 2013, 30
12345